← FDA Drug Approvals (Drugs@FDA)

RYALTRIS

NDA · New Drug Application · Sponsor: GLENMARK SPECLT · Approved 2022-01-13

Drug application

FDA Application #

NDA211746

Application type

New Drug Application

Brand name

RYALTRIS

Generic name

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE

Active ingredients

MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

GLENMARK SPECLT

Manufacturer

HIKMA SPECIALTY USA INC.

First approval

2022-01-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown